Biodiversity and the Pharmaceutical sector: The Convention on Biological Diversity (CBD), the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits in Vietnam’s context

Biodiversity and the Pharmaceutical sector: The Convention on Biological Diversity (CBD), the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits in Vietnam’s context

by | Sep 9, 2024 | Practitioner

Abstract Biodiversity has never ceased to be an imminent topic, and healthcare and the pharmaceutical sector have remained in the spotlight in recent years. On one hand, the pharmaceutical sector is often concerned with promoting access to medicinal products, many of...
error: Content is protected !!